Mulmit

Keros Therapeutics, Inc.Keros Therapeutics, Inc.

KROS Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-31244,061,00067,569,00087,014,0002.3
2024-12-313,550,000-210,833,000-187,353,000-5
2023-12-31151,000-169,941,000-152,992,000-5.2
2022-12-310-114,790,000-104,679,000-4.15
2021-12-3120,100,000-56,373,000-58,744,000-2.52

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-18Tanini AnnitaCorp. Controller & VP, Finance1,224
2026-08-18Cho EstherChief Legal Officer4,485
2026-08-18Lerner Lorena RaquelChief Scientific Officer3,568
2026-08-18Newton Charles W.551
2026-08-17BIENAIME JEAN JACQUES1,000
2026-07-15BIENAIME JEAN JACQUES1,000
2026-07-01Prener Anne13,786
2026-07-01Prener Anne14,870
2026-06-15BIENAIME JEAN JACQUES1,000
2026-06-11Newton Charles W.550
2026-06-04Knowles Julius2,625
2026-06-04Farzan Nima2,625

8-K events

FiledItems
2026-08-03Regulation FD disclosure · Financial statements and exhibits
2026-08-03Results of operations · Financial statements and exhibits
2026-07-30Regulation FD disclosure · Financial statements and exhibits
2026-07-22Officer or director change
2026-06-25Officer or director change · Regulation FD disclosure · Financial statements and exhibits
2026-06-03Submission of matters to a vote
2026-06-01Regulation FD disclosure · Financial statements and exhibits
2026-05-14Results of operations · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.